Chimeric Therapeutics Limited (ASX:CHM)

Chimeric Therapeutics Revenue

In the fiscal year ending June 30, 2026, Chimeric Therapeutics had annual revenue of -189.85K AUD. Chimeric Therapeutics had revenue of -2.81M in the half year ending June 30, 2026. That makes Chimeric Therapeutics the 48,076th largest company in the world by revenue and 1,601st in Australia.

• Revenue: -189.85K
• Revenue Growth: n/a
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 354.39K

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	-189.85K	-12.87M	-
Jun 30, 2025	12.68M	5.23M	70.09%
Jun 30, 2024	7.46M	2.95M	65.52%
Jun 30, 2023	4.51M	1.89M	72.16%
Jun 30, 2022	2.62M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 15, 2026

Data Sources Report a data error